Efficacy of Unani Medicine and regimen in Post stroke disability

Efficacy of Munzij wa Mushil-e-Balgham, Majoon-e-Hindi and Dalk with Roghan-e-Laqwa in Functional Independence Recovery of Post Stroke patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012862

Enrollment

Registered

2018-03-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- According to the inclusion and exclusion criteria in this trial patients having stroke and disability had been selected.

Interventions

Intervention1: DECOCTION OF MUNZIJ-e-BALGHAM, DECOCTION OF MUSHIL-e-BALGHAM, MAJOON-e-HINDI, and ROGHAN-e-LAQWA: DECOCTION OF MUNZIJ-e-BALGHAM contain (Badyan (Foeniculum vulgare Mill.), Maweez Munaqq

DECOCTION OF MUSHIL-e-BALGHAM containing Ustukhuddus (Lavandula stoechas Linn.) 5 gm, Barg Sana (Cassia angustiafolia) 10 gm, Turbud (Operculina turpethum) 3 gm, Maghz faloos (Cassia fistula) 7 gm, an

MAJOON-e-HINDI comprising Filfil Siyah (fruits of Piper nigrum) Peepal (Piper chaba Linn.), Waj (Acorus calamus), Taj (Cinnamomum cassia), Baobarang (Embelia ribes), Sheetraj (Plumbago zeylancia Linn.

ROGHAN-e-LAQWA contains Irsa (Iris ensata Thunb.) and Lehsun (Allium sativum Linn.) in equal ratio. DOSAGE: DECOTION OF MUNZIJ BALGHAM GIVEN ONCE BEFORE BREAKFAST FROM 0th day to 12th day daily in abo

Eligibility

Inclusion criteria

Inclusion criteria: (i) Subjects who gave voluntary informed consent (ii) Age between 18-65 years and either gender (iii) >= 1 month to 5 years of stroke onset (iv) Hemiplegia secondary to stroke (ischemic/ heamorrhagic) (v) Stroke clinically or radiologically confirmed (vi) Baseline FIM score <= 90.

Exclusion criteria

Exclusion criteria: (i) Patients with altered sensorium, aphasia, serious enough to impair understanding of simple commands; (ii) A life threatening advanced systemic illness; (iii) Pregnancy and lactation; (iv) Transient Ischemic Attack (TIA); (v) Conditions, where massage is contraindicated.

Design outcomes

Primary

Measure	Time frame
POST STROKE DISABILITY, FUNCTIONAL INDEPENDENCE MEASURES (FIM) AND TIME UP AND GO TEST (TUG)Timepoint: FIM scale: 0th, 12th, 14th, and 30th. (It is measures in numbers from 1 to 7, where 1 denotes total assistance Subject contributes 25% of the effort or is unable to do the task and 7 denotes Complete independence). TUG test: 0th, 12th, 14th, and 30th. This scales measure total time taken by the patient to perform the task in Seconds.	—

Measure

Time frame

POST STROKE DISABILITY, FUNCTIONAL INDEPENDENCE MEASURES (FIM) AND TIME UP AND GO TEST (TUG)Timepoint: FIM scale: 0th, 12th, 14th, and 30th. (It is measures in numbers from 1 to 7, where 1 denotes total assistance Subject contributes 25% of the effort or is unable to do the task and 7 denotes Complete independence). TUG test: 0th, 12th, 14th, and 30th. This scales measure total time taken by the patient to perform the task in Seconds.

—

Secondary

Measure	Time frame
Safety profile includes Hb%, TLC, DLC, ESR, FBS, PPS, S.CREATININE, S.URIC ACID, SGOT, SGPT, ALK.PHOSPATE, T.BILIRUBINTimepoint: Safety profile: 0th day and 30th day of the trial	—

Countries

India

Contacts

Public ContactMOHD SHAHID

HAKIM RAIS UNANI MEDICAL COLLEGE AND HOSPITAL

mansoor.nium@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026